{
    "abstract": "FreeStyle Libre (FSL) monitoring is available for all patients in Wales with insulin-treated diabetes. English guidance permits FSL in patients with type 1 diabetes mellitus (T1D) and type 2 diabetes mellitus (T2D) requiring multiple daily insulin doses (MDI) (National Institute for Health and Care Excellence 2023). The literature suggests benefits from using FSL, specifically improved glycaemic control and reduced hypoglycaemia.\nPatients aged\u2009>18 years with insulin-treated T2D using FSL for\u2009\u2265\u20093 months were identified from Libreview. Those with pre- and post-FSL HbA1c were included. Days 1-14 of FSL data were taken as baseline. Patients were categorised by insulin regime (OD basal, premixed, basal bolus).\n236 patients were identified and 189 patients included. The median follow-up duration was 14.6 [10.3-15.0] months. There were significant reductions in median HbA1c [8 mmol/mol, \nImprovements in HbA1c were greatest in those taking OD basal or premixed insulins. Reductions in hypoglycaemia are likely to positively impact quality of life. Further studies will elucidate whether these improvements are directly related to improved quality of glycaemic data facilitating closer treatment titration, or behaviour changes related to FSL use.",
    "authors": [
        {
            "affiliation": "Diabetes Centre, Morriston Hospital, Swansea Bay University Health Board, Swansea, SA6 6NL UK.",
            "firstname": "Michael",
            "initials": "M",
            "lastname": "Atkinson"
        },
        {
            "affiliation": "Diabetes Centre, Morriston Hospital, Swansea Bay University Health Board, Swansea, SA6 6NL UK.",
            "firstname": "David M",
            "initials": "DM",
            "lastname": "Williams"
        },
        {
            "affiliation": "Diabetes Centre, Morriston Hospital, Swansea Bay University Health Board, Swansea, SA6 6NL UK.",
            "firstname": "Elin",
            "initials": "E",
            "lastname": "Crockett"
        },
        {
            "affiliation": "Diabetes Centre, Morriston Hospital, Swansea Bay University Health Board, Swansea, SA6 6NL UK.",
            "firstname": "Isaac",
            "initials": "I",
            "lastname": "Hathaway"
        },
        {
            "affiliation": "Diabetes Centre, Morriston Hospital, Swansea Bay University Health Board, Swansea, SA6 6NL UK.",
            "firstname": "May",
            "initials": "M",
            "lastname": "Mon"
        },
        {
            "affiliation": "Diabetes Centre, Morriston Hospital, Swansea Bay University Health Board, Swansea, SA6 6NL UK.\nDiabetes Research Group, Swansea University Medical School, Swansea University, Swansea, SA2 8QA UK.",
            "firstname": "Jeffrey W",
            "initials": "JW",
            "lastname": "Stephens"
        },
        {
            "affiliation": "Diabetes Centre, Morriston Hospital, Swansea Bay University Health Board, Swansea, SA6 6NL UK.\nDiabetes Research Group, Swansea University Medical School, Swansea University, Swansea, SA2 8QA UK.\nDiabetes Centre, Neath Port Talbot Hospital, Baglan Way, Port Talbot, SA12 7BX UK.",
            "firstname": "Thinzar",
            "initials": "T",
            "lastname": "Min"
        }
    ],
    "conclusions": null,
    "copyrights": "\u00a9 The Author(s), under exclusive licence to Tehran University of Medical Sciences 2025. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.",
    "doi": "10.1007/s40200-025-01572-1",
    "journal": "Journal of diabetes and metabolic disorders",
    "keywords": [
        "Flash glucose monitoring",
        "FreeStyle libre",
        "Hypoglycaemia",
        "Type 2 diabetes mellitus"
    ],
    "methods": null,
    "publication_date": "2025-03-05",
    "pubmed_id": "40041676\n8366922\n20518803\n16306561\n18215172\n35141761\n34593612\n30095980\n33496979\n26657725\n34334726\n28000140\n33836819\n35476279\n33644623\n36944104\n36094418\n33879536\n34149259\n38001509\n33948909",
    "results": "236 patients were identified and 189 patients included. The median follow-up duration was 14.6 [10.3-15.0] months. There were significant reductions in median HbA1c [8 mmol/mol, ",
    "title": "Assessing glycaemic impact of FreeStyle libre monitoring in patients with insulin-treated type 2 diabetes: a retrospective real-world analysis.",
    "xml": "<Element 'PubmedArticle' at 0x788502fd6cf0>"
}